This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
APOBEC3G targets human T-cell leukemia virus type 1
Retrovirology Open Access 19 May 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H . Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481–492.
Uchiyama T . Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15: 15–37.
Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15–20.
Yasuda N, Lai PK, Ip SH, Kung PC, Hinuma Y, Matsuoka M et al. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71: 1021–1026.
Yoshida M . Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475–496.
Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y et al. Target epitope in the tax protein of human T-cell leukemia-virus type-I recognized by class-I major histocompatibility complex-restricted cytotoxic T-cells. J Virol 1992; 66: 2928–2933.
Ishikawa T, Ichinohe T, Imada K, Uchiyama T . Allogeneic hematopoietic stem cell transplantation for ATL. In: Kannagi M (ed). Two Decades of Adult T-Cell Leukemia and HTLV-I Research. Tokyo, Japan: Scientific Societies Press, 2003, pp 253–262.
Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y et al. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 1386–1392.
Acknowledgements
This work was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology. We are very grateful to Drs Yasuharu Ezumi and Yasunori Ueda (Kurashiki Central Hospital) for supplying blood samples from patients.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hishizawa, M., Imada, K., Ishikawa, T. et al. Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation. Leukemia 18, 167–169 (2004). https://doi.org/10.1038/sj.leu.2403204
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403204
This article is cited by
-
Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
Journal of NeuroVirology (2017)
-
Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma
Leukemia (2007)
-
APOBEC3G targets human T-cell leukemia virus type 1
Retrovirology (2005)